Viracor, Transplant Genomics: John Holman, Roz Mannon, Michael Abecassis, Fuad Shihab, Win Williams, Anil Chandraker, Allan Kirk, Jonathan Bromberg, Robert Fairchild, Matt Cooper
Transplant Genomics (TGI) and Viracor Eurofins announced that they have formed the Eurofins Transplant medical and scientific advisory board, which will be convened by Eurofins TGI's VP of Medical Affairs John Holman. The board will include Roz Mannon, University of Nebraska; Michael Abecassis, University of Arizona; Fuad Shihab, University of Utah; Win Williams, Massachusetts General Hospital; Anil Chandraker, Brigham and Women's Hospital; Allan Kirk, Duke University; Jonathan Bromberg, University of Maryland; Robert Fairchild, Cleveland Clinic; and Matt Cooper, Georgetown University.
The board consists of people with diverse expertise and experience in transplantation technology development and clinical studies, and will be tasked with providing independent advice on unmet clinical needs in transplantation to guide the evolution of TGI and Viracor's current and future products that expand the indications for its TruGraf and Trac product lines through clinical studies. The board will also provide advice on R&D or acquisition of additional disruptive technologies for the Eurofins transplant portfolio.